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Bacterial vaginosis (BV) is the most common cause of abnormal vaginal discharge in reproductive age women. It is associated with
increased susceptibility to HIV/STI and adverse birth outcomes. Diagnosis of BV in resource-poor settings like India is challenging.
With little laboratory infrastructure there is a need for objective point-of-care diagnostic tests. Vaginal swabs were collected from
women 18 years and older, with a vaginal pH > 4.5 attending a reproductive health clinic. BV was diagnosed with Amsel’s criteria,
Nugent scores, and the OSOM BVBlue test. Study personnel were blinded to test results. There were 347 participants enrolled
between August 2009 and January 2010. BV prevalence was 45.1% (95% confidence interval (CI): 41.5%–52.8%) according to Nugent
score. When compared with Nugent score, the sensitivity, specificity, positive predictive value, negative predictive value for Amsel’s
criteria and BVBlue were 61.9%, 88.3%, 81.5%, 73.7% and 38.1%, 92.7%, 82.1%, 63.9%, respectively. Combined with a “whiff ” test,
the performance of BVBlue increased sensitivity to 64.4% and negative predictive value to 73.8%. Despite the good specificity, poor
sensitivity limits the usefulness of the BVBlue as a screening test in this population. There is a need to examine the usefulness of
this test in other Indian populations.

1. Introduction
Finding effective methods to diagnose bacterial vaginosis
(BV) has taken on increased urgency since BV was associated
with a greater than 3-fold increased risk of female-to-male
HIV-1 transmission and a doubling of risk for acquiring
sexually transmitted infections [1–4]. BV has also been
implicated in neonatal morbidity [5], preterm delivery [6–
8], and low birth weight infants [9]. BV is usually diagnosed
using Amsel’s criteria [10] or Nugent scoring of Gram-stained
vaginal smears [11] both of which require microscopy. In
countries like India where access to laboratory services is
often limited, BV is typically managed using a syndromic
approach for vaginal discharge, a method with low sensitivity
and specificity [12]. Point-of-care (POC) testing may improve

diagnosis of BV by providing accurate results without laboratory or on-site microscopy [13].
Several different approaches have been used in POC
testing for BV. Rapid assays detecting the presence of proline
amino peptidase [14, 15] have been found to have high
sensitivity and specificity. Others which rely on detection
of trimethylamine and high vaginal pH have not been
compared favorably with Amsel’s criteria or Nugent scoring
[16–18]. BVBlue, a chromogenic POC, diagnoses BV based
on elevated levels of sialidase, an enzyme produced by anaerobic flora including Bacteroides, Prevotella, and Gardnerella
species [19, 20]. In other studies, this approach has been
shown to have excellent sensitivity, specificity, and predictive
values in several populations [21–24].
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This paper describes a study comparing the performance
of BVBlue point-of-care test (OSOM BVBlue Test, Gryphus
Diagnostics, Birmingham, AL, USA) with Amsel’s criteria
and Nugent scoring of Gram-stained vaginal smears among
women attending a reproductive health clinic in Mysore,
India.

2. Materials and Methods
2.1. Study Population. Between August 2009 and January
2010, a consecutive sample of 347 nonpregnant, sexually
active women were recruited prospectively from a reproductive health clinic in Mysore, India, into a cross-sectional
study comparing the performance of the BVBlue POC test
to Amsel’s criteria and Nugent scoring of Gram-stained
vaginal smears. To be included in the study, participants were
required to be 18 years of age or older, have had vaginal intercourse at least once in the previous three months, be willing to
undergo a pelvic examination, and have a vaginal pH over 4.5.
Vaginal pH was measured by placing a self-collected vaginal
swab on a BDH pH test strip and comparing the color to a
pH chart provided by the manufacturer (VWR International,
West Chester, PA, USA). The pH strip was read by a research
assistant responsible for assessing participant eligibility. The
Committee for Protection of Human Subjects at University of
California, Berkeley, CA, USA and the Institutional Review
Board at Public Health Research Institute of India (PHRII),
Mysore, India, approved the study protocol. All participants
provided written informed consent to participate in the study.
2.2. Data Collection. After undergoing an informed consent
process, trained interviewers collected information on demographics and reproductive/sexual health using a standardized
questionnaire. Biological samples, questionnaires, and clinician checklists were labeled with a unique identifier to ensure
confidentiality of participants.
2.3. Examination and Specimen Collection. A trained study
clinician performed a pelvic examination and collected three
swabs of vaginal fluid from the posterior fornix of the vagina
in a random order to test for BV, Trichomonas vaginalis, and
vaginal candidiasis. In addition, clinical signs from external
and internal examination were recorded on a medical chart.
Signs of vaginal discharge including amount, odor, color,
and consistency were noted. Diagnosis was based on Amsel’s
criteria: presence of any three of four clinical features: a characteristic homogeneous white adherent vaginal discharge,
a vaginal pH greater than 4.5, a positive amine test, and
presence of 3–5 clue cells per high power field on wet-mount
microscopy [10]. Symptomatic women diagnosed with BV by
Amsel’s criteria were treated according to standard Indian
treatment guidelines.
2.4. Laboratory Assessment. All tests were performed by three
trained laboratory research assistants in a blinded manner
to prevent bias. Saline wet-mount preparation of vaginal
fluid was examined microscopically within five minutes of
collection for clue cells, motile trichomonads, and yeast
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buds/hyphae. The vaginal swab was placed in a test tube
containing 3 drops of sterile normal saline at the time of
pelvic examination by the clinician. After agitation, 1 drop of
solution was placed on a glass slide, covered with a cover slip,
and observed at 10x and 40x magnifications. Another drop of
the saline solution was placed on a sterile glass slide with an
added drop of KOH solution. The slide was used for detection
of amine odor (whiff test). Following the whiff test, a cover
slip was placed on the slide and read for detection of budding
yeast or hyphae. Wet-mount examinations were part of the
routine clinical care at this clinic and hence the time interval
between specimen collection and microscopy was less than
five minutes.
A second vaginal swab was placed in the BVBlue test
vessel containing the chromogenic substrate of bacterial
sialidase and the mixture was gently swirled. The BV test
vessel containing the swab was left standing for 10 minutes.
One drop of developer solution was added to the BV test
vessel and the mixture was swirled gently again. Results were
read immediately; a blue or green color in the BV test vessel
or on the head of the swab was considered positive and a
yellow color in the BV test vessel was considered negative.
If the results were not blue/green or yellow, then the test
was repeated. A positive result indicated an elevated level
of sialidase activity and a negative result indicated a normal
level.
The third vaginal swab was smeared on a glass slide
and air-dried before fixing and Gram-staining at the PHRII
laboratory. The swab was then used to inoculate InPouchTV
culture kit (Biomed Diagnostic, White City, OR, USA), for
detection of T. vaginalis infection. The swab was inserted
in the upper chamber, agitated in the medium, and discarded, and the pouch was sealed. The contents of the upper
chamber were immediately expressed into the lower chamber
by rolling down. The pouch was then transported to the
laboratory within four hours and placed in a 37∘ C incubator.
It was read without opening the culture or sampling the
contents for five days or until trichomonads were detected
using a microscope at 10x and 40x magnification.
Each Gram-stained slide was scored by two different
trained laboratory assistants masked to the other test results
to minimize bias. In cases of discrepancy, the slide was
then scored by a third reader blinded to the scores of the
first two readers. The Nugent score is a standardized 0–
10-point scoring system based on the presence of three
bacterial morphotypes: large gram-positive rods (Lactobacillus spp.), small gram-negative or gram-variable coccobacilli
(Gardnerella and anaerobic spp.), and curved gram-variable
rods (Mobiluncus spp.) [11]. A Nugent score (NS) of 0–3
is classified as the presence of “normal” flora, 4–6 as the
presence of “intermediate” flora, and 7–10 as BV. This method
is still considered the gold standard for diagnosis of BV.
2.5. Quality Control. The expiration dates of all test kits were
recorded before use. Kits were refrigerated between 2 and
8 degrees Celsius and kept out of direct sunlight. All BV
vessels were stored inside the box as suggested by the manufacturer, and kits were brought to room temperature before
use. For quality control purposes, test vessels were checked
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before use to ensure that they contained only a colorless liquid
without sediments. The BVBlue test result was only reported
if there was appearance of blue/green or yellow color in the
testing vessel. We also conducted 10% random quality control
checks by an experienced microscopist who has expertise in
BV for Nugent’s scoring and wet-mount preparation readings
for clue cells and found high concordance.
2.6. Data Analysis. Data were entered and stored in Microsoft
Access and analyzed using Stata 10.1 (Stata Corporation,
College Station, TX). Proportions were compared using chisquare and Fisher’s exact tests where appropriate, and 95%
confidence intervals (CIs) were calculated. Participants were
excluded from the analysis if complete clinical information
or specimens were not available. Sensitivity, specificity, and
predictive values were calculated using a traditional standard
defined as Nugent score of 7–10 for BV positivity. Analyses
were carried out in two ways: first, women with an NS of 4–
6 (“intermediate” flora) were classified as negatives; second,
women with “intermediate” flora were excluded, and the
performance of the rapid test was calculated for each analysis.
We also stratified the women based on their complaints into
symptomatic (excess vaginal discharge, odor, burning, and
itching) and asymptomatic cases to examine the performance
of the rapid test. Sensitivity and specificity were calculated for
each testing method using the following formulas:
Sensitivity: (number of true positives/(number of true
positives + number of false negatives))∗100;
Specificity: (number of true negatives/(number of true
negatives + number of false positives))∗100.

3. Results
3.1. Population Characteristics. Figure 1 describes the number of women eligible who did not participate in the study and
the reasons for not participating. Twelve participants were
excluded because of missing laboratory results. (Seven were
missing BVBlue results, and five Nugent score.) Among the
total participants, 221 (71%) women reported symptoms of
abnormal vaginal discharge, pruritus, burning, or odor at the
time of enrollment. The characteristics of these participants
are described in Table 1. The median age of the patients
was 33 years and the vast majority (87%) reported their
religion as Hindu. Eighty-seven (58.3%) women diagnosed
with BV complained of vaginal symptoms, and 62 (41.6%)
were asymptomatic.
3.2. Burden of BV among Participants. About 206 (63.7%)
women had abnormal vaginal flora with an NS of 4–10, and
149 (46%) were diagnosed with BV (NS 7–10) (Figure 1).
Using Amsel’s criteria, 111 (35%) women were diagnosed with
BV and 68 (21.9%) by the BVBlue POC test. T. vaginalis
infection was common among women with BV (NS: 7–10) as
compared to women without BV (18% versus 8.6%; 𝑃 = 0.02).
3.3. Performance of BV Diagnostic Methods. A positive
BVBlue test result was strongly associated with two of Amsel’s
criteria: the presence of clue cells (𝑃 < 0.0001) and amine
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Table 1: Characteristics of study population according to BV status
diagnosed by Nugent score (7–10) among sexually active women in
Mysore, India, between August 2009 and January 2010 (𝑁 = 323).
Characteristic
Total
Age categories
18–25 yrs
26–35 yrs
≥36 yrs
Education level
No education
Up to 5 years of school
6 to 9 years of school
≥10 years
Religion
Hindu
Other
Yeast infection on
microscopyb
No
Yes
Trichomonas vaginalis by
culture and/microscopyb
No
Yes

Total
𝑁 (%)

BV Presenta
𝑛
(%)

323

100

149

46.1

34
169
120

10.5
52.3
37.2

15
70
64

44.1
41.4
53.3

133
46
75
69

41.2
14.2
23.2
21.4

64
21
33
31

48.1
45.6
44.0
44.9

𝑃 value

0.13

0.94

0.14
281
42

87.0
13.0

133
15

47.7
35.7
0.45

171
151

53.1
46.9

76
73

44.2
48.3
0.04

276
45

86.0
14.0

122
27

44.2
60.0

Note: Data are % (no.) of participants unless otherwise indicated.
a
BV positive defined according to Nugent score of 7–10; b denominator may
vary because of missing data.

odor (𝑃 < 0.0001). Table 2 shows the BVBlue POC test
performance compared to wet-mount microscopy, Amsel’s
method, and Nugent scoring among a subset of women
where women with intermediate flora were excluded from
the analysis. Table 3 shows the performance of BVBlue test
as compared to Amsel’s criteria and Nugent score. With
BV positive being defined as NS of 7–10 and all other
results considered negative including the intermediates (NS:
0–6), BVBlue performance was not very different among
symptomatic women as compared to all women.
3.4. Test Sensitivity among Women with Symptoms. Among
symptomatic women with complaint of any vaginal symptom,
Amsel’s criteria had the best sensitivity followed by wet
mount microscopy and BVBlue with Nugent score being
considered the gold standard. The BVBlue test performance
did not improve (in terms of sensitivity and specificity)
among symptomatic women as compared to its performance
among all women (Tables 2 and 3).
3.5. Performance of BVBlue Combined with Amine Test. Used
alone, a positive amine odor (whiff test) was highly specific
(87.9%) but had a low sensitivity (59.7%). Combined use of
a whiff test and the BVBlue POC test, however, improved
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Screened patients
Ineligible (n = 101)
Younger than 18 years; had no vaginal
intercourse in the last 3 months; not willing
to undergo a pelvic examination; vaginal
pH less than 4.5

(N = 448)

Eligible patients
(N = 347)

Excluded
∙ Bleeding (n = 7)

∙ Refused (n = 5)

n = 323 participants

Intermediate
n = 57;
17.6%

Amsel s Criteria

BV Blue test

Nugent score

Negative
n = 117;
36.2%

∙ Missing laboratory results (n = 2)

Positive
n = 149;
46.1%

Negative
n = 244;
78.2%

Positive
n = 68;
21.8%

Negative
n = 212;
65.6%

Positive
n = 111;
34.4%

Figure 1: Enrolment figures for the study evaluating OSOM BVBlue Rapid Test among women in Mysore, India, between August 2009 and
January 2010.
Table 2: Characteristics of the diagnostic tests used for detection of bacterial vaginosis among sexually active women with intermediate flora
(Nugent score 4–6) excludeda .
Test
Amsel’s criteria
Wet-mount microscopy
BVBlue

Sens%
61
46
38

Bacterial vaginosis (Nugent score 7–10)
All women (𝑁 = 266)b
Symptomatic women (𝑁 = 156)b
95% CI
Spec%
95% CI
Sens%
95% CI
Spec%
95% CI
(55–67)
92
(88–95)
64
(57–72)
96
(93–99)
(40–52)
98
(96–99)
49
(42–57)
97
(95–100)
(32–44)
95
(92–97)
37
(30–45)
95
(92–99)

a

Nugent score of 0–3 considered negative, and 7–10 considered positive. Women with NS of 4–6 were excluded from this analysis. b Number varies because of
missing data. Sens: sensitivity; Spec: specificity; PPV: positive predictive value; NPV: negative predictive value. Amsel’s criteria defined as presence of any three
of the four characteristics: vaginal pH > 4.5, presence of amine odor on addition of 10% potassium hydroxide (whiff test), presence of 3–5 clue cells per high
power field on wet-mount microscopy, and homogenous vaginal discharge.

the sensitivity of BV diagnosis to 64.4%. Diagnosing BV with
a BVBlue POC test and/or amine test result was found to
be the best performing approach with high sensitivity and
minimal loss of specificity as compared to Amsel’s criteria.

4. Discussion
Our study examined the performance of the BVBlue POC
test as compared to Amsel’s criteria and Nugent scoring of
Gram stains among women with and without symptoms of
BV. Our results showed that BVBlue test had poor sensitivity
in detecting BV (38.1%) but was highly specific (92.7%)
in a population of women attending a reproductive health
clinic in Mysore, India. In previous research, BVBlue has
been shown to perform well compared with conventional
diagnostic methods for the diagnosis of BV in populations

in Canada, Australia, Thailand, Malaysia, and China [21, 24–
26]. Sensitivity ranged from 88% to 100% and specificity
from 95% to 97.8% using Nugent Gram stain as a gold
standard. The only study from North India showed that the
BVBlue test had 97.6% sensitivity and 97.5% specificity as
compared to Nugent score of Gram stain [23]. However, our
findings were similar to another study that examined the
performance of BVBlue for diagnosis of bacterial vaginosis
in symptomatic and asymptomatic women in the US. That
study found BVBlue test was less sensitive than Gram stain
for diagnosis of BV and not statistically different from Amsel’s
criteria [27].
Because our results were substantially different from
previous evaluations of the BVBlue, we considered and
eliminated several alternative explanations for the difference.
Our samples were collected by a trained study clinician who
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Table 3: Performance of BVBlue Rapid Test compared to the results of Amsel’s criteria and Nugent score among sexually active women in
Mysore, India, between August 2009 and January 2010.

All women
Symptomatic women

Variables
Amsel’s criteriaa
Nugent scoreb
Amsel’s criteriaa
Nugent scoreb

𝑁
323
266
188
156

Sens% (95% CI)
51 (46–57)
38 (32–44)
52 (44–59)
37 (30–45)

Spec% (95% CI)
94 (92–97)
95 (92–97)
95 (92–98)
95 (92–99)

PPV% (95% CI)
82 (78–87)
90 (87–94)
85 (80–90)
91 (87–96)

NPV% (95% CI)
78 (74–83)
54 (48–60)
79 (73–85)
54 (46–61)

a
All women were included in this analysis comparing Amsel’s criteria to BVBlue Rapid Test. Women with intermediate flora included as negatives (0–6) and
NS of 7–10 considered BV positive. b Women with intermediate flora (NS of 4 to 6) excluded from this analysis comparing Nugent score to BVBlue Rapid Test.
Sens: sensitivity; Spec: specificity; PPV: positive predictive value; NPV: negative predictive value.

was an experienced obstetrician/gynecologist and processed
within five minutes of the time that the physical examination
was finished. So we believe that the quality of the specimens
was adequate for evaluation. Our team had been extensively
trained and recently completed several studies using Nugent
score reading of several thousand Gram stains, so we ruled
out systematic human error in the diagnosis of BV [28–33].
We had conducted quality control checks by an experienced
microscopist for Nugent scoring and wet mount readings for
clue cells and found high concordance. Finally, we ruled out
manufacturing or handling problems with BVBlue kits by
checking refrigerator logs and contacting the manufacturer
to enquire about known quality issues with the manufacture
or handling of the kits. Having examined and dismissed those
alternative explanations, we speculate that the BVBlue POC
kit was not sensitive in this population because of differences
in the composition and diversity of the vaginal bacterial flora
among women with BV in our sample. Recent studies using
broad-range 16S rRNA gene PCR and pyrosequencing have
shown that BV is a highly heterogeneous condition marked
by greater species richness and diversity than previously
thought, with no single species universally present [34].
Since the BVBlue kit operates on the principle that BV is
associated with elevated levels of sialidases, it is possible
that the vaginal biota of women with BV in our study
population may have sialidase-negative G. vaginalis strains
or contain a low number of anaerobic Gram-negative rods
such as Prevotella spp. and Bacteroides spp. that are common
sources of sialidases in BV. Previous studies have shown that
sialidase activity was detected in only 75% to 84% of women
[35, 36] with BV, suggesting that the presence of sialidase
is not uniform. Studies have also demonstrated that the
composition of BV flora varies by race/ethnicity, raising the
possibility that BV-related bacteria in this population may be
different from those found in other racial and ethnic groups
[34, 37].
There are several limitations to this study. First, we
did not evaluate the performance of the rapid test using
molecular methods such as polymerase chain reaction (PCR)
for diagnosis of BV. Currently, Nugent scoring of Gram stains
continues to be the gold standard for diagnosis of BV in
research studies, but it is possible that results might have
been different if molecular diagnostic methods had been
used. Second, corroborating low sialidase levels in the vaginal
fluid of participants would have been useful in helping to
explain the poor sensitivity of the BVBlue POC test, but it

was beyond the scope of this study. Finally, we were not able
to definitively establish the fitness of BVBlue kits used in the
study since we were not provided with an external control by
the manufacturer.
There is an important public health need for development
of POC tests that facilitate diagnosis of BV in settings without
adequate laboratory infrastructure. However, BVBlue test
does not appear to be a good screening test in our population.
Unfortunately, the effectiveness of different methods may
depend on the bacterial composition of BV flora in different
populations giving added importance to the need for wide
evaluation of POC tests. Furthermore, given the heterogeneity of BV, culture-based methods for characterizing
the vaginal biota may have to give way to more exacting
molecular methods to detect and characterize a greater range
of organisms. Additional research should also be conducted
to analyze differences in vaginal biota of different populations
in India and other parts of the world.
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